Clinical Research Directory
Browse clinical research sites, groups, and studies.
Investigation of Laser Assisted Drug Delivery of NanoDOX®
Sponsor: Massachusetts General Hospital
Summary
This is a self-controlled single-site study of healthy subjects receiving an ablative fractional CO2 (carbon dioxide) laser procedure followed by topical application of NanoDOX® Hydrogel (1% doxycycline). The study includes skin biopsies to evaluate the effects of NanoDOX® Doxycycline Monohydrate Gel on wound healing after the ablative laser procedure. Study subjects will be asked to do 2 visits of 4 hours in total over approximately 1 week. An optional third visit will take place approximately 6 weeks after Visit 1. In this study, 20 subjects are expected to enroll with a goal of 12 healthy subjects to enroll and complete the study.
Official title: Self-controlled, Single-site Trial Investigation of Laser Assisted Drug Delivery of NanoDOX®
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2023-11-29
Completion Date
2026-04
Last Updated
2025-10-28
Healthy Volunteers
Yes
Conditions
Interventions
NanoDOX® Hydrogel
NanoDOX® Hydrogel (Doxycycline Monohydrate USP) will be applied on the areas of the skin previously treated by the Co2 Ablative Fractional Laser and also on a small non treated area of the subject's skin
CO2 Ablative Fractional Laser
CO2 Ablative Fractional Laser will be applied to healthy skin areas
Locations (1)
MGH Clinical Unit for Research Trials And Outcome
Boston, Massachusetts, United States